A 7-year experience with the surgery of biliopancreatic diversion in the modification of Hess-Marceau for the treatment of morbid obesity and type 2 diabetes
https://doi.org/10.14341/omet2012243-48
Abstract
We examined 292 patients (mean age 37,5±9,1 years) with morbid obesity (initial BMI 47,3±7,0 kg/m2), from which 72 patients had type 2 diabetes, before and after biliopancreatic diversion in Hess-Marceau modification, conducted from 2003 to 2010. Along with a significant and steady weight loss, the most important advantage of surgery is its high efficiency in treatment of disturbances in carbohydrate and lipid metabolism in patients with morbid obesity and associated type 2 diabetes and severe atherogenic dyslipidemia.
References
1. Buchwald H. Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers. Surgery for obesity and related diseases (SOARD) 2005;1:371-81.
2. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch: results beyond 10 years. Obes. Surg 2005;15:408-16.
3. Marceau P, Biron S, Bourque RA. et al. Biliopancreatic diversion with a new type of gastrectomy. Obesity surgery 1993;3:29-35.
4. Reinhold RB. Critical analysis of long term weight loss following gastric bypass. Surg. Gynecol. Obstet 1982;155:385-94.
5. Scopinaro N, Gianetta E, Adami GF. et al. Biliopancreatic Diversion. World J. Surg 1998;22:936-46.
Review
For citations:
, , , , A 7-year experience with the surgery of biliopancreatic diversion in the modification of Hess-Marceau for the treatment of morbid obesity and type 2 diabetes. Obesity and metabolism. 2012;9(2):43-48. (In Russ.) https://doi.org/10.14341/omet2012243-48
Views:
383
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
